EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expanding clones, expanding aneurysms through macrophage-to-osteoclast differentiation

Jessica A Regan, Svati H Shah

Journal of Clinical Investigation · 15.04.2026 · 136 (8)

DOI: 10.1172/jci206748 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.04.2026. Verfasst von Jessica A Regan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology. Hauptthemen laut MEDLINE: Aortic Aneurysm, Abdominal, Clonal Hematopoiesis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abdominal aortic aneurysms (AAAs) are an age-related cause of sudden cardiac death and cardiovascular disease (CVD) morbidity with limited nonsurgical treatment options. In this issue of the JCI , Yonekawa et al. addressed the pathobiologic mechanisms of clonal hematopoiesis (CH), the age-related acquisition of expanded somatic clones in blood cells, as a potential driver of AAA. CH prevalence was high in patients being treated for AAA, and faster AAA expansion occurred over a period of one year in CH carriers. In an angiotensin II–induced model of AAA, mice carrying ten-eleven translocation 2 ( Tet2 ) mutations ( Tet2 -CH) displayed accelerated AAA development and macrophage reprograming to an osteoclast-like state. Inhibition of this differentiation, targeting RANK/RANKL with FDA-approved therapies like alendronate and denosumab, suppressed aneurysmal growth. These findings suggest that macrophage-to-osteoclast differentiation may underlie the risk and progression of AAA associated with age-related CH, a mechanism that is modifiable through existing therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Aneurysm, AbdominalClonal HematopoiesisHumansAnimalsMiceHeterozygoteDisease Models, AnimalMacrophagesAngiotensin IIMice, TransgenicDNA-Binding ProteinsDioxygenasesMutationCell DifferentiationOsteoclastsReceptor Activator of Nuclear Factor-kappa BRANK LigandSignal TransductionAlendronateDenosumabMaleFemale

Substanzen

Angiotensin IITet2 protein, mouseDNA-Binding ProteinsDioxygenasesReceptor Activator of Nuclear Factor-kappa BRANK LigandAlendronateDenosumab

Autor:innen und Institutionen

  • Division of Cardiology.
  • Duke Molecular Physiology Institute, and.
  • Duke Center for Precision Health, Duke University School of Medicine, Durham, North Carolina, USA.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Regan, J. A., & Shah, S. H. (2026). Expanding clones, expanding aneurysms through macrophage-to-osteoclast differentiation. Journal of Clinical Investigation, 136(8). https://doi.org/10.1172/jci206748

Vancouver

Regan JA, Shah SH. Expanding clones, expanding aneurysms through macrophage-to-osteoclast differentiation. Journal of Clinical Investigation. 2026;136(8). doi:10.1172/jci206748

BibTeX
@article{Regan2026,
  author = {Regan, Jessica A and Shah, Svati H},
  title = {Expanding clones, expanding aneurysms through macrophage-to-osteoclast differentiation},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {8},
  doi = {10.1172/jci206748}
}
Kostenlos starten →